Portal Innovations

Syntis Bio operates as a late-stage preclinical company that develops oral therapies for obesity, diabetes, and rare diseases.

Synaptrix is a healthcare company that offers medical products for postoperative pain treatment.

CrossBridge Bio operates as a biotechnology company.

March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.

SyntaxBio develops genetic programming platform that can program cells without the need for consistent external intervention.

Alnair Therapeutics is a preclinical stage precision oncology platform focusing on developing innovative approaches to treat difficult.

Dimension Inx specializes in developing regenerative microenvironments that give the body a blueprint to heal itself.

Syntis Bio operates as a late-stage preclinical company intended to develop a new class of therapy.

Cardiosense is a digital biomarker platform that provides multi-sensor devices and proprietary algorithms to detect early signs of diseases.

Rhaeos is a medical device company that develops wearable sensors to improve the treatment of chronic health conditions.